Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.99
Schlusskurs vom Vortag:
$2.99
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$10.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$5.84
Entero Therapeutics Inc Stock (ENTO) Company Profile
Firmenname
Entero Therapeutics Inc
Sektor
Branche
Telefon
561-589-7020
Adresse
777 YAMATO ROAD, BOCA RATON
Vergleichen Sie ENTO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENTO
Entero Therapeutics Inc
|
0.00 | 10.05M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
447.38 | 114.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
748.71 | 78.80B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
396.04 | 51.80B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
847.05 | 53.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.55 | 42.33B | 447.02M | -1.18B | -906.14M | -6.1812 |
Entero Therapeutics Inc Aktie (ENTO) Neueste Nachrichten
What valuation multiples suggest for Entero Therapeutics Inc. stockJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - Улправда
ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer - Treasure Coast News
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy - Lubbock Avalanche-Journal
What drives Entero Therapeutics Inc stock priceVolume Profile Analysis & Low Risk Trading Alerts - earlytimes.in
Entero Regains Nasdaq Compliance With Grid AI Acquisition - The News Leader | Staunton, VA
GridAI Technologies announces board changes and rebranding - MSN
Entero Therapeutics Inc Stock Analysis and ForecastDividend Aristocrats List & Exceptional Growth Portfolio - earlytimes.in
Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX" - Lohud
GridAI Technologies Corp. Announces Appointment of Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - The Florida Times-Union
GridAI Technologies Announces Board Changes and Rebranding - The Globe and Mail
GridAI Technologies Corp. Announces Board and Committee Changes - marketscreener.com
GridAI Technologies Corp. Appoints Marshall Chapin as Chief Executive Officer of wholly-owned operating subsidiary GridAI, Inc - marketscreener.com
GridAI Technologies (NASDAQ: GRDX) taps Marshall Chapin to lead AI data-center grid unit - Stock Titan
Entero Therapeutics Stock Jumps After Company Rebrands As GridAI Technologies Corp. - MSN
GRDXGridAI Technologies Corp Stock Price and Quote - Finviz
Entero Therapeutics, Inc. (ENTO) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Entero Therapeutics Stock Gains 5% Ahead Of Name Change To GridAI - Nasdaq
Entero Therapeutics (ENTO) to Rebrand as GridAI (GRDX) Technologies - GuruFocus
Entero Therapeutics to Change Name to GridAI Technologies - marketscreener.com
Entero Therapeutics stock rises ahead of name change to GridAI By Investing.com - Investing.com UK
Entero Therapeutics stock rises ahead of name change to GridAI - Investing.com India
Finanzdaten der Entero Therapeutics Inc-Aktie (ENTO)
Es liegen keine Finanzdaten für Entero Therapeutics Inc (ENTO) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):